Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma
NCT04203472
Asthma, Bronchial Diseases
Warsaw, Poland
View Trial DetailsNCT Number: NCT00660114
This open label, non-interventional study is to show the efficacy of Pulmicort®Respules® in cough variant asthma in patient aged 5-year old or younger in outpatient department
Looking for future studies?
Notify MeUp to 5 year
All sexes
Observational
Research Site, Hefei, Anhui, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 weeks (plus or minus 3 days )
Time frame: 7 weeks (plus or minus 3 days )
Time frame: 7 weeks (plus or minus 3 days )
AstraZeneca
Industry
A Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Patient Aged 5-Year Old or Younger in Outpatient Department
Acronym: PUL NIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04203472
Asthma, Bronchial Diseases
Warsaw, Poland
View Trial DetailsNCT01064245
Asthma, Bronchial Diseases
Kingston, Ontario, Canada
View Trial DetailsNCT03573284
Asthma, Bronchial Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT03363698
Allergic Rhinitis, Asthma
Warsaw, Masovian Voivodeship, Poland
View Trial Details